Ribavirin (Sandoz Inc)
Welcome to the PulseAid listing for the Ribavirin drug offered from Sandoz Inc. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Ribavirin |
SUBSTANCE NAME: | RIBAVIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2006-10-03 |
END MARKETING DATE: | 0000-00-00 |
Ribavirin HUMAN PRESCRIPTION DRUG Details:
Item Description | Ribavirin from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2006-10-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-5177_206ad017-3b96-4732-9366-1906c9dbf957 |
PRODUCT NDC: | 0781-5177 |
APPLICATION NUMBER: | ANDA077743 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers: